CompletedNot Applicable

Effect of Metformin on Patients With Polycystic Ovary Syndrome

China77 participantsStarted 2020-06-01

Plain-language summary

The purpose of the study is to understand the effect of Metformin on patients with PCOS.

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Individuals who are 20 to 40 years old, planning to become pregnant or infertile women.

✕. Individuals who can insist on continuous monitoring in the outpatient clinic. Individuals who are not participating in other research projects currently or 3 months before the intervention.
✕. Volunteers with polycystic ovary syndrome without insulin resistance.
✕. Individuals who suffering from other diseases that may cause hyperandrogenism and ovulation abnormalities.
✕. Individuals who are during pregnant, lactation or menopause.
✕. Individuals who currently receiving weight-loss drugs or surgery or within the past 2 months.
✕. Individuals who take niacin, nicotinamide, or other vitamin B3-related supplementation currently or within the past 2 months.
✕. Individuals who need regular medication to treat chronic diseases such as diabetes, hypertension, gout, hyperuricemia, etc.
✕. Use of medications that affect hormone levels, appetite, carbohydrate absorption, and metabolism within the past 2 months.

Luteinizing hormone in serum

Timeframe: before and after 2, 12 weeks of intervention

4-Androstenedione in serum

Timeframe: before and after 2, 12 weeks of intervention

NCT IDNCT05802212

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-01